Richtlijn: Niet-kleincellig longcarcinoom (2.0) - Kwaliteitskoepel

cancer and brain metastases. J Clin Oncol 2009;27:5255-5261.530 - Socinski MASocinski MA, Schell MJ, Peterman A, et al. Phase III trial comparing a defined duration of therapy versuscontinuous therapy followed by second line therapy in advanced-stage IIIB/IV non–small-cell lung cancer. JClin Oncol 20:1335-1343, 2002.531 - Solis LMSolis LM, Raso MG, Kalhor N, Behrens C, Wistuba II, Moran CA. Primary oncocytic adenocarcinomas ofthe lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases. Am J ClinPathol 133:133-140, 2010.532 - Soon YYSoon YY, Stockler MR, Askie LM, Boyer MJ. Duration of chemotherapy for advanced non–small-cell lungcancer: A systematic review and meta-analysis of randomized trials. J Clin Oncol 2009;27; 3277-3283.533 - Soorae ASSoorae AS, Stevenson HM. Survival with residual tumor on the bronchial margin after resection forbronchogenic carcinoma. J Thorac Cardiovasc Surg 78:175-180, 1979.534 - Soresi ESoresi E, Clerici M, Grilli R, Borghini U, Zucali R, Leoni M, et al. A randomized clinical trial comparingradiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locallyadvanced non-small cell lung cancer. Semin Oncol 15(Suppl 7):20-25, 1988535 - Spiro SGSpiro SG, Rudd RM, Souhami RL, Brown RL, Fairlamb DJ, Gower NH, Maslove L, Milroy R, Napp V,Parmar MKB, Peake MD, Stephens RJ, Thorpe H, Waller DA, West P, on behalf of all the Big Lung Trialparticipants. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improvedsurvival without detriment to quality of life. Thorax 59:828-836, 2004.536 - Strauss GMStrauss GM, Herndon JE, II, Maddaus MA, Johnstone DW, et al. Adjuvant Paclitaxel Plus CarboplatinCompared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer andLeukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group StudyGroups. J Clin Oncol 26:5043-5051, 2008.537 - Sugi KSugi K, Nawata K, Fujita N, Ueda K, Tanaka T, Matsuoka T, et al. Systematic lymph node dissection forclinically diagnosed peripheral non-small-cell lung cancer less than 2 cm in diameter. World J Surg;22:290-294, 1998.538 - Sun LMSun LM, Leung SW, Wang CJ, Chen HC, Fang FM, Huang EY, et al. Concomitant boost radiation therapyfor inoperable non-small-cell lung cancer: preliminary report of a prospective randomized study. Int J RadiatOncol Biol Phys 47:41341-8. 2000.539 - Sunaga NSunaga N, Tomizawa Y, Yanagitani N, et al. Phase II prospective study of the efficacy of gefitinib for thetreatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previouschemotherapy. Lung Cancer 56:383-389, 2007.540 - Sutani ARichtlijn: Niet-kleincellig longcarcinoom (2.0)Sutani A, Nagai Y, Udagawa K, et al. Gefitinib for non-small-cell lung cancer patiënts with epidermal growthfactor receptor gene mutations screened by peptide nucleic acid-locked nucleic acid PCR clamp. Br JCancer 95:1483-1489, 2006.541 - Swensen SJSwensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary06/09/2011 Niet-kleincellig longcarcinoom (2.0) 133